Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NBY - NovaBay Pharmaceuticals looking to grow its three verticals of eye skin and wound care in 2023

NBY - NovaBay Pharmaceuticals looking to grow its three verticals of eye skin and wound care in 2023

NovaBay Pharmaceuticals Inc.

--News Direct--

NovaBay Pharmaceuticals CEO Justin Hall joined Steve Darling from Proactive to talk more about the company that has developed scientifically proven eye care, skin care and wound care products. The company's top product is Avenova, which has proven in laboratory testing to have broad antimicrobial properties as it removes foreign material and debris from the skin around the eye, including the eyelid.

Hall telling Proactive the company acquired DermaDoctor, a skincare brand, in 2021. He emphasizes that all their products are doctor-recommended and clinically developed to address specific needs.

NovaBay aims to excel in all three verticals, including wound care, and expects continued growth and success.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/novabay-pharmaceuticals-looking-to-grow-its-three-verticals-of-eye-skin-and-wound-care-in-2023-274486627

Stock Information
Company Name: NovaBay Pharmaceuticals Inc.
Stock Symbol: NBY
Market: NYSE
Website: novabay.com
Menu
NBY NBY Quote NBY Short NBY News NBY Articles NBY Message Board
Get NBY Alerts

News, Short Squeeze, Breakout and More Instantly...